Laure F.
- Country
- France
- Department
- MEDICAL ONCOLOGY
Research Overview
- IFCT-2201 ADAPTABLE A non-comparative randomized phase II trial evaluating the combination of paclitaxel-bevacizumab ± atezolizumab in patients with advanced non-squamous NSCLC progressing after immunotherapy and chemotherapy
- Phase 3 Study of Trastuzumab Deruxtecan vs. Platinum-Based Chemotherapy in HER2-Mutant Unresectable or Metastatic NSCLC
- Efficacy and Safety of Lorlatinib Monotherapy in Advanced ROS1-Positive Non-Small Cell Lung Cancer Post First-Line TKI Failure
Data & Insights
Has run more than one trial at 104 of 283 partner sites.
Specializations
Gynecologic Oncology
The investigator specializes in treating complex gynecologic malignancies, with particular emphasis on ovarian cancer therapeutics. Their research encompasses various subtypes including small cell ovarian carcinoma and non-mucinous epithelial ovarian cancer.
- Platinum-sensitive recurrent ovarian cancer management
- Advanced stage ovarian cancer treatments
- MMR deficient endometrial cancer
A key focus lies in developing combination approaches using immunotherapy and chemotherapy for gynecologic cancers.
Thoracic Oncology
The investigator has extensive experience in treating non-small cell lung cancer (NSCLC), particularly focusing on targeted therapies for specific molecular alterations.
- HER2-mutated NSCLC treatment
- EGFR Exon 20 insertion mutations
- Advanced and metastatic lung cancer therapies
Their work includes evaluating novel therapeutic combinations for locally advanced and metastatic disease.
Immunotherapy Research
The investigator demonstrates significant expertise in immunotherapeutic approaches across multiple cancer types.
- Checkpoint inhibitor combinations
- Novel immunotherapy agents
- Maintenance therapy strategies
Their research explores innovative immunotherapy combinations with conventional treatments for enhanced therapeutic outcomes.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.